CC BY
17
Abstracts. PHYTOPHARM 2017
importance and interest of researchers in this plant, probably because of the alternative potential this species has, in addition to official therapies for diabetes.
Acknowledgments: UNEMAT, FLOBIO Research Group, FAPEMAT
References:
1. Rieder A, Rodrigues FAC. 2012. Caceres: Unemat. 25 p.
2. Rieder A. Guarim Neto G. 2012. Caceres: UNEMAT Publisher. 94 p.
PLANTS USED IN DIABETES THERAPY IN MATO GROSSO (BRAZIL) AND WITH ADVERSE EFFECTS
© Arno Rieder, Tatiane Gomes de Almeida
University of the State of Mato Grosso (UNEMAT): Caceres, Mato Grosso, Brazil
Diabetes is increasing in the world. Alternative and complementary therapies are welcome. Phytotherapy is one of them and, in the plants used, phytochemistry finds bioactive substances. Some may have a therapeutic effect on diabetes. There may also be an adverse effect, depending on the type of substances, concentrations and mixtures. Plants for therapeutic purposes should be chosen by checking for potential adverse effects. It is revealed medicinal plants used for diabetes control in Mato Grosso (MT), Brazil (BR) and, which also show to have harmful, attractive or repellent effect. In a first step, in a specific study1, a list of plants used in the control of diabetes in MT was constituted. In a second stage, on these plants, we sought popular knowledge1, essays2, literature3 and lifelong learning. This aimed to find other biological effects in these plants (attractive, repellent, nefarious). In the first stage a list of 133 species used to control diabetes in MT was identified, which were distributed in 52 botanical families. In the second stage, there were 9 species among those that had some effect on other organisms (insects, molluscs, etc.). Acting as attractive insects (ants, beetles, bees) has three species [Embauba (Cecropia pachystachya Trecul.- Cecropiaceae), Melon of Sao Caetano (Momordica charantia L. - Cucurbitaceae), Lixeira (Curatella americana L. - Dilleniaceae)], as insect repellent (mosquitoes, mosquitoes) and herbivores
(in general) there are two species [Negramina (Siparuna guianensis Aubl. - Monimiaceae), Losna (Artemisia absinthium L. - Asteraceae)] and, with insecticidal effect (Diptera larvae, Lepidoptera, etc.) there are five species" [two Anonaceae: Ata (Annona dioica A.St.-Hyl.), Graviola (A. muricata L.); Two Asteraceae: Losna (A. absinthium L.), Carqueja (Baccharis trimera (Less.) DC and; Quina (Strychnos pseudoquina A.St.-Hil.- Loganiaceae)]. Two plants (Losna, Carqueja) also have an effect against molluscs, bacteria and other microorganisms4. These plants should receive special attention and care and, if used medicinally, only under professional guidance. May have potential to help in the control of synanthropic pests, mainly in urban environments (households, health units, public roads, commercial houses)
Acknowledgments: FLOBIO Research Group (Bioactive Flora Study) UNEMAT / CNPq / FAPEMAT
Reference:
1. Rieder A. Guarim Neto G. 2012. Caceres: UNEMAT Publisher. 94 p.
2. Rieder A, Lima LG, Straub AL. 2011. Plant Med; 77. (3).
3. Rieder A, Rodrigues FAC. 2012. Caceres: Unemat. 25 p.
4. Barbosa FS. 2007. Medicinal plants: effect on pest insects and their natural enemies. Montes Claros, MG: NCA / UFMG, xiv, 80 p.
VITEX AGNUS CASTUS EXTRACT BNO 1095 IS AN EFFECTIVE INHIBITOR OF UTERINE CONTRACTIONS AND INFLAMMATION AS SYMPTOMS OF PRIMARY DYSMENORRHEA
© Röhrl J., Ammendola A., Abramov-Sommariva D., Künstle G.
Bionorica SE, Neumarkt, Germany
Many women suffer monthly from menstrual cramps severely enough that their quality of life is severely disrupted. In the case of primary dysmenorrhea, a condition related to premenstrual syndrome (PMS), intense uterine contractions are thought to trigger moderate to intense pain despite the absence of an
underlying infection or other medically-identifiable disease states. The associated pain is likely to be mediated by the release of inflammatory mediators such as prostaglandins, leukotrienes and the infiltration of leukocytes that normally accompany the breakdown of the endometrial lining.
Obzory po kliniceskoj farmacologii i lekarstvennoj terapii [Reviews of clinical pharmacology and drug therapy]
vol. 15/2Q17/suppLeMEnt 1
